# FDA EIR - GlaxoSmithKline LLC - July 15, 2016

Source: https://www.keypedia.com/records/eir/glaxosmithkline-llc/be8f57d1-5818-4270-9aa4-bafffac721e9

> FDA EIR for GlaxoSmithKline LLC on July 15, 2016. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: EIR
- Company Name: GlaxoSmithKline LLC
- Inspection Date: 2016-07-15
- Product Type: drugs
- Office Name: Atlanta District Office
- Summary: An FDA inspection of GlaxoSmithKline (GSK) in Durham, NC, was conducted from July 12-15, 2016. The inspection focused on ensuring compliance with postmarketing adverse drug experience (PADE) reporting laws and regulations under the Food and Drug Cosmetic (FD&C) Act, and adherence to the Risk Evaluation and Mitigation Strategy (REMS) program for the drug Tanzeum. While a formal Form FDA-483 (Inspectional Observations) was not issued, the inspection highlighted several areas for improvement. Main issues discussed with management included the need to formally integrate all training guidances, particularly for after-hours reporting and electronic submissions, into employee training curricula and evaluate them for official approval. Additionally, inconsistencies were noted in the documentation and verbiage of corrective and preventive actions (CAPAs) for 15-day late adverse drug experience reports, underscoring the necessity for standardization to facilitate effective trending and prevent recurrence. A previously resolved issue involved an incorrect system configuration for an over-the-counter product (Gaviscon), which led to paper submissions to the wrong FDA center. GSK management acknowledged and agreed to address the discussed observations.

## Related Documents

- [EIR - 2012-08-09](https://www.keypedia.com/records/eir/glaxosmithkline-llc/7552b94f-49df-400e-aa75-b62fdb80583f)
- [EIR - 2015-04-10](https://www.keypedia.com/records/eir/glaxosmithkline-llc/c0defc2a-5c08-451d-97ba-748c53905495)

## Related Officers

- [company_representative](https://www.keypedia.com/people/barbara-j-devans/26f4d01e-e0c0-4a8d-8493-f0a5581ad1ed)
- [Commissioned Corps of the U.S. Public Health Service](https://www.keypedia.com/people/adam-r-cooke/337c005d-e9dc-4512-aadb-ee0b0c637bd5)
- [company_representative](https://www.keypedia.com/people/deanna-minter/3701c429-0a5f-4bda-b0db-66d64a4b1920)
- [company_representative](https://www.keypedia.com/people/brian-f-jellema/5a9f8106-b1fb-4fed-8f60-6fe70a24ec3d)
- [company_representative](https://www.keypedia.com/people/theresa-r-haughey/5eaf3871-3875-4e7e-8e0b-82a99946ecc0)

Company: https://www.keypedia.com/companies/glaxosmithkline-llc/3e32166b-cf0c-496b-b725-b1687e48a928

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7